Bionoid Pharma Inc is a technology-focused company developing proprietary software solutions that leverage artificial intelligence (AI) and automation to optimize customer acquisition and audience engagement... Show more
BINP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 20 cases where BINP's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BINP's RSI Indicator exited the oversold zone, of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 30 cases where BINP's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for BINP just turned positive on July 02, 2025. Looking at past instances where BINP's MACD turned positive, the stock continued to rise in of 28 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on July 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BINP as a result. In of 44 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BINP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for BINP entered a downward trend on July 22, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows